Active, Not Recruiting
Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
NCT05271162
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +6 more
- Locations
-
- Institute of Hematology and Transfusion Medicine Warsaw, Poland
- National Institute of Oncology Warsaw, Poland